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Sinus node dysfunction (SND) affects 9% of patients with
single-ventricle physiology that are palliated via the Fontan
procedure, and pacemaker implantation has become the most
common cardiac procedure in this population.1,2 It has been
shown that in addition to the increased procedural risk
inherent to open surgery, the epicardial approach is asso-
ciated with higher pacing thresholds, lower sensing thresh-
olds, and faster battery depletion compared with transvenous
(TV) placement.3 Unfortunately, the commonly utilized extra-
cardiac lateral tunnel (ECLT) technique, where a prosthetic orFigure 1 Example of an extracardiac lateral tunnel Fontan circuit.
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venous return to the pulmonary arterial circulation, precludes
TV access to the atria (Figure 1).4,5
Newcombe et al6 reported a successful TV lead placement
for SND in a patient with an ECLT Fontan constructed with
autologous pericardium. Here, the authors were able to map
atrial tissue within the Fontan bafﬂe. For patients without
paceable tissue in the Fontan pathway, 2 studies have
recently described a transpulmonary technique whereby the
patient’s atrial endocardium was accessed via TV puncture
into a branch pulmonary artery, followed by advancement of
the pacing lead into the common atrium.7,8 We report 2
additional cases where TV pacemaker implantation was
attempted in 2 patients with both SND and ECLT Fontan
anatomy.Case report
Case 1
The patient was a 20-year-old man with a history of
heterotaxy, unbalanced atrioventricular canal, double-outlet
right ventricle, interrupted inferior vena cava with azygos
continuation to the left-sided superior vena cava, and hepatic
venous drainage to the right atrium. He underwent a left
bidirectional Glenn (Kawashima) procedure at 21 months of
age, with residual hepatic venous drainage to the inferior
common atrium. Finally, he underwent an ECLT Fontan and
atrioventricular valvuloplasty at 10 years of age, with
tunneling of his hepatic veins to the pulmonary arterial
conﬂuence via an 18-mm Gore-Tex tube graft. He presented
at 20 years old with 6 months of progressive fatigue and
palpitations, and was found to have sinus pauses43 seconds
on Holter monitoring and a maximum heart rate of 102 beats
per minute on exercise testing. He was taken for hemody-
namic catheterization, during which time he also underwent
a pacing study that documented several potential pacing sites
in the posterior inferior aspect of the Fontan bafﬂe, near the
anastomosis with the hepatic veins.pen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2016.07.006
Figure 2 Posterior-anterior and left lateral chest radiographs of ﬁnal lead
position for Case 1.
KEY TEACHING POINTS
 Sinus node dysfunction affects 9% of patients with
single ventricle physiology that are palliated to a
Fontan circulation.
 Pacemaker implantation is the most common
procedure performed in patients with Fontan
circulation.
 Transvenous lead implantation spares patients the
morbidity and complications of open surgery, yet
requires systemic anticoagulation.
 Transvenous lead implantation in patients with
extracardiac lateral tunnel Fontans is possible,
though technically challenging. Paceable tissue
may be found within the bafﬂe itself or via
transpulmonary access to the native atrium.
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was taken to the catheterization lab for TV atrial pacemaker
implantation. Venous access was obtained via the left
subclavian vein. Hand contrast injections were used to
visualize the Fontan pathway and potential pacing sites
identiﬁed in the previous catheterization. Numerous sites
were sampled with the permanent pacing lead and high
thresholds were noted in the inferior portion of the Fontan
bafﬂe. More lateral areas resulted in diaphragmatic capture.
It was only when the lead was secured to the posterior
inferior aspect of the bafﬂe near the presumed anastomosis
with hepatic veins that an adequate capture threshold was
noted. Stable lead position was conﬁrmed ﬂuoroscopically.
Unfortunately, pacemaker interrogation noted loss of capture
several hours after the procedure and chest radiograph
(CXR) showed lead dislodgement. The procedure was
unsuccessfully reattempted the following day owing to a
combination of poor pacing/sensing thresholds, continued
lead dislodgement, and inadvertent capture of the phrenic
nerve. It was decided to abort the procedure and reattempt at
a later time, given the patient’s preference to avoid another
open surgical procedure. One month later he returned to the
catheterization laboratory, where adequate pacing/sensing
thresholds were found in the posterolateral aspect of the
inferior hepatic bafﬂe (Figure 2). A Medtronic SelectSecure
49-cm bipolar lead was ﬁxated at this site and connected to a
Medtronic Adapta ADSR01 generator. Capture threshold
was found to be 1.50 V at 0.40 msec. He was discharged
home on warfarin with target international normalized ratio
of 2.0–3.0.
At most recent follow-up (4 months from implantation),
the patient continues to have adequate lead function, with a
capture threshold of 1.0 V at 0.40 msec, and stable lead
position on CXR. Unfortunately, he has missed several
follow-up appointments, which is concerning, given his
systemic anticoagulation and need for international normal-
ized ratio monitoring.Case 2
The patient was a 14-year-old boy with a history of tricuspid
atresia, ventricular septal defect, D-transposition of the great
arteries, and pulmonary stenosis. He underwent bidirectional
Glenn placement at 1 year of age and ECLT Fontan at 2 years
of age. Subsequently, he developed SND requiring epicardial
pacemaker implantation at 7 years of age at an outside
facility. At presentation, his pacemaker showed progressive
evidence of lead failure with atrial and ventricular non-
capture resulting in 2-second pauses, in addition to declining
impedance in the atrial lead. A 24-hour Holter monitor
further demonstrated these ﬁndings, with multiple examples
of atrial and ventricular non-capture.
Given these ﬁndings and with the generator approaching
its elective replacement indicator, it was decided to proceed
to pacemaker revision with both generator change and lead
replacement. In an effort to try and limit patient morbidity, a
TV approach was ﬁrst attempted. Access was obtained via
the right internal jugular vein, purposefully done to test for
pacing sites prior to creating a pocket or violating the left
subclavian vein. Contrast hand injections showed an unob-
structed Fontan pathway and bilateral pulmonary arteries.
With a deﬂectable decapolar catheter, atrial capture was
demonstrated at the left pulmonary artery/Fontan junction,
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atria. A Boston Scientiﬁc Fineline II pacing lead (Model
4469) was then inserted via the right internal jugular vein.
Despite trying numerous locations and screwing the lead
deep into the atrial tissue, the lowest capture threshold in this
region was 3.1 V at 0.5 msec. Given the inability to pace the
atrium at acceptable outputs, sheaths and leads were
removed and the procedure was aborted.
He then underwent dual-chamber epicardial lead place-
ment (with 60-cm Medtronic 4968 leads) and a generator
change (Medtronic Adapta ASDR01) 6 days later with an
uncomplicated intraoperative and initial postoperative
course. Atrial capture threshold was 2.0 V at 0.40 msec,
and he was discharged on postoperative day 3. Unfortu-
nately, he presented 6 days after discharge to clinic with
pallor and tachypnea. CXR was obtained, which showed a
left-sided pleural effusion occupying roughly 25% of the left
hemithorax. After an outpatient trial of enteral furosemide
failed to resolve symptoms, he was admitted to the hospital
for parenteral furosemide and standing ibuprofen. He was
discharged 4 days later on maintenance enteral furosemide in
addition to a 2-liter ﬂuid restriction per day. At clinic follow-
up 3 months from discharge a CXR showed only a faint
residual left-sided effusion and enteral furosemide was
discontinued. His atrial capture threshold nearly 1 year from
implantation remains adequate at 2.0 V at 0.4 msec.Discussion
These cases serve as 2 additional examples of TV pacemaker
implantation attempts in patients with ECLT Fontans, and
highlight the beneﬁts, risks, and complexities one must
consider when deciding on a transvenous vs epicardial
approach.
Patients in whom transvenous leads are being considered
should have their Fontan pathway mapped before a pace-
maker pocket is created or a permanent lead inserted.
Mapping of the bafﬂe can be considered during an interven-
tional catheterization procedure that does not involve electro-
physiological interventions, which could also delineate the
proximity of the pulmonary arterial vasculature to the atrium
via angiography. Depending on how the bafﬂes are created
and the material of which they are made, isolated islands of
paceable tissue may be available within the bafﬂe itself, or, in
some cases, via transpulmonary access. In patients without a
need for heart catheterization, cardiac computed tomography
can be considered to better understand the anatomical
relationship of the Fontan pathway with the common atrium
and determine whether transvenous pacing is potentially
feasible.8
“Hunting” for paceable tissue is a relatively straightfor-
ward task. Use of a deﬂectable catheter via the internal
jugular vein allows for sites to be tested prior to the
pacemaker site being violated (ie, without the creation of a
pacemaker pocket or access to the axillary or subclavian
vein). Once viable tissue is found, use of a permanent pacing
lead via the internal jugular vein can conﬁrm whether thereare acceptable pacing and sensing thresholds, and whether
there is capture of the phrenic nerve. This approach allows
the physician to quickly rule out, or conﬁrm, the ability to
place a transvenous lead without signiﬁcant risk to the
patient.
The likelihood of success may primarily be dictated by
how the surgeon created the Fontan bafﬂe. In Case 1, the
presence of an interrupted inferior vena cava resulted in the
inferior limb of the Fontan being anastomosed to the hepatic
veins. This likely left a remnant of atrial tissue that could be
paced. Although this tissue is not typically present in ECLT
Fontans, this case may highlight the utility of leaving a cuff
of atrial tissue in the inferior portion of all extracardiac
bafﬂes in case atrial pacing is required in the future. This
could negate the need for transpulmonary atrial lead place-
ment, along with its inherent risk of cardiac perforation, and
systemic emboli and stroke.8
Unfortunately, even with paceable tissue present, our
cases illustrate the technical difﬁculty of securing a lead in
the appropriate location. Lead dislocation is more likely to
occur given the complex course the lead travels from the
innominate vein and through the Fontan. This is often a
tortuous route, with numerous turns as the lead passes from
the innominate vein, into the superior vena cava, through a
native branch pulmonary artery, and then into the bafﬂe
itself. Once there, the bafﬂe itself is relatively narrow, adding
to the difﬁculty in maneuvering the lead into the correct
position. The tortuous lead course often leads to difﬁculty
screwing the lead into the myocardium. After securing the
lead, the distal electrode may then have limited contact with
the endocardial surface of the atrium, resulting in unaccept-
ably high atrial capture thresholds.
Despite the difﬁculties associated with TV leads in ECLT
Fontans, they do provide a useful alternative to epicardial
leads. A transvenous lead can spare the patient a repeat
sternotomy or thoracotomy and the potential for pleural or
pericardial effusions, perioperative bleeding, and prolonged
hospital stays that are known to complicate the epicardial
approach in this population.9,10 However, as illustrated in
this case series, the acute beneﬁts of a TV lead must be
balanced with the patient’s risk for venous thromboembo-
lism and potential for nonadherence with anticoagulation
regimens.11 To our knowledge, no studies have demon-
strated the safety and/or efﬁcacy of the novel anticoagulants
in preventing thrombosis in TV systems. Future investiga-
tions into this area would be beneﬁcial.Conclusion
In conclusion, TV lead placement in patients with Fontan
circulations are a good alternative to open surgery and
epicardial leads, especially with intra-atrial lateral tunnel
bafﬂes that have easily accessible atrial tissue to be paced.
Our series provides an approach to mapping patients with
ECLT to determine their candidacy for a transvenous lead,
and provides evidence that TV lead implantation in ECLT
Fontans is feasible, despite previously being viewed as a
Heart Rhythm Case Reports, Vol 2, No 6, November 2016498contraindication owing to the lack of paceable tissue. This
may be particularly true in extracardiac tunnels constructed
with autologous pericardium, which theoretically allows for
conduit growth with the patient.4,6 After discussion with the
patient regarding risks and beneﬁts of a TV vs epicardial
system, including the long-term need for anticoagulation and
potential for thrombosis in the former, we recommend that
patients who choose to proceed with a TV device have their
extracardiac tunnel mapped via the jugular vein prior to the
creation of a pacemaker pocket. This adds minimal risk to the
patient and potentially saves the patient from the complica-
tions inherent to epicardial pacemakers. Long-term follow-
up and further studies would be needed to determine the risk
of thromboembolic complications.
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